MedTrace Logo

Epidemiological Characteristics of COVID-19 in Patients With MS or NMO

NCT04355611 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 2465

Last updated 2024-02-05

No results posted yet for this study

Summary

The purpose of this study is to collect French medical data for patients with Multiple Sclerosis (MS) or NeuroMyelitis Optica (NMO) spectrum disorder who are diagnosed or strongly suspected of being infected with Covid19. The objective of this study is to provide scientific information regarding the possible risk factors in these patients, as a large part of them receive immunomodulatory or immunosuppressive treatments. The main objective of this study is thus to determine the epidemiological (eg, age, form of disease, disability) and pharmacological (related to immunomodulatory or immunosuppressive treatments) factors favoring the occurrence of a severe form of Covid-19 in MS and NMO patients.

Conditions

Interventions

OTHER

Evaluation of the epidemiological characteristics of coronavirus infection (SARS-CoV-2)

Epidemiological characteristics of coronavirus infection (SARS-CoV-2) in patients with MS or NMO

Sponsors & Collaborators

  • Assistance Publique - Hôpitaux de Paris

    lead OTHER

Eligibility

Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2020-04-17
Primary Completion
2022-06-30
Completion
2022-06-30

Countries

  • France

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT04355611 on ClinicalTrials.gov